Bioengineering bacterial outer membrane vesicles as vaccine platform

Biotechnology Advances
Matthias J H GerritzenMichiel Stork

Abstract

Outer membrane vesicles (OMVs) are naturally non-replicating, highly immunogenic spherical nanoparticles derived from Gram-negative bacteria. OMVs from pathogenic bacteria have been successfully used as vaccines against bacterial meningitis and sepsis among others and the composition of the vesicles can easily be engineered. OMVs can be used as a vaccine platform by engineering heterologous antigens to the vesicles. The major advantages of adding heterologous proteins to the OMV are that the antigens retain their native conformation, the ability of targeting specific immune responses, and a single production process suffices for many vaccines. Several promising vaccine platform concepts have been engineered based on decorating OMVs with heterologous antigens. This review discusses these vaccine concepts and reviews design considerations as the antigen location, the adjuvant function, physiochemical properties, and the immune response.

Citations

Mar 3, 2018·Vaccines·Pumtiwitt C McCarthyLaleh Sheikhi Moghaddam
Feb 15, 2018·Applied and Environmental Microbiology·H Bart van den Berg van SaparoeaJoen Luirink
Aug 3, 2018·Expert Review of Proteomics·Tobias KronigerDörte Becher
Aug 8, 2018·FEMS Microbiology Letters·Peter van UlsenJoen Luirink
Apr 2, 2019·Angewandte Chemie·Jorge RoyesChristophe Tribet
Jun 18, 2019·Advanced Materials·Jiarong ZhouLiangfang Zhang
May 18, 2020·Vaccines·Kalyan K DewanEric T Harvill
Oct 2, 2020·Advanced Healthcare Materials·Yulan WangYufeng Zhang
Jun 20, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesca MicoliPaolo Costantino
Jun 25, 2020·International Journal of Molecular Sciences·Francesca ManciniFrancesca Micoli
Sep 6, 2020·Microbial Cell Factories·Jorge RoyesBruno Miroux
May 17, 2018·Frontiers in Cellular and Infection Microbiology·Michael P HaysPhilip R Hardwidge
May 10, 2019·NPJ Vaccines·Emily KayBrendan W Wren
Mar 9, 2019·Nature Communications·Vipul GujratiVasilis Ntziachristos
Apr 10, 2019·Clinical and Experimental Immunology·A Miquel-ClopésS R Carding
Jun 2, 2020·Frontiers in Microbiology·H Bart van den Berg van SaparoeaWouter S P Jong
Jul 19, 2019·Frontiers in Cellular and Infection Microbiology·Uchini S KosgodageJameel M Inal
Oct 9, 2019·Proceedings of the National Academy of Sciences of the United States of America·Carmela IreneGuido Grandi
Aug 28, 2020·Frontiers in Immunology·Biswajit MaitiØystein Evensen
Apr 10, 2019·Clinical and Experimental Immunology·J WallisR C Carlisle
Sep 26, 2019·Frontiers in Cellular and Infection Microbiology·Uchini S KosgodageSigrun Lange
Jun 17, 2020·Expert Opinion on Drug Delivery·Qirong TongGuangxi Zhai
May 29, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Keman ChengXiao Zhao
Oct 13, 2020·Critical Reviews in Microbiology·Roghayeh MohammadzadehSaman Soleimanpour
Sep 29, 2019·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Linglei JiangRaymond M Schiffelers
Jan 28, 2021·International Journal of Molecular Sciences·Layaly ShkairSvetlana F Khaiboullina
Feb 9, 2021·Expert Review of Vaccines·Crystal Ma, Wangxue Chen
Feb 23, 2021·Frontiers in Microbiology·Melanie D BalhuizenHenk P Haagsman
Mar 2, 2021·Journal of Extracellular Vesicles·Ilaria ZanellaGuido Grandi
Dec 21, 2018·Current Opinion in Chemical Engineering·Kevin B WeyantMatthew P DeLisa
Mar 30, 2021·Advanced Drug Delivery Reviews·Mina MehannyGregor Fuhrmann
May 27, 2020·Biochemistry·Xiangzhao AiLiangfang Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.